| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 2,406.20 | -391.50 | -3,143.90 | -385.00 |
| Net Changein Cash | 413.80 | -74.80 | -170.00 | 2,372.90 |
| Cash Taxes Paid | 1,801.90 | 1,285.80 | 592.00 | 674.60 |
| Net Income/ Starting Line | 6,026.70 | 4,808.90 | 2,589.70 | 2,838.10 |
| Total Cash Dividends Paid | -302.50 | -621.00 | -267.10 | -372.20 |
| Changesin Working Capital | -391.70 | -2,270.80 | -1,139.90 | -1,333.30 |
| Cashfrom Operating Activities | 6,793.30 | 3,202.30 | 2,688.80 | 2,078.20 |
| Cashfrom Financing Activities | 2,014.20 | -1,778.80 | -4,400.40 | -868.30 |
| Issuance( Retirement)of Stock Net | 0.00 | -725.00 | -863.20 | - |
| Depreciation/ Depletion | 915.80 | 764.10 | 722.70 | 736.10 |
| Other Investing Cash Flow Items Total | -6,659.70 | -568.60 | 2,565.90 | 2,357.00 |
| Capital Expenditures | -1,712.60 | -906.60 | -1,030.90 | -1,202.60 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | -21.40 | -23.10 | 6.60 | 8.60 |
| Non- Cash Items | 242.50 | -99.90 | 516.30 | -162.70 |
| Financing Cash Flow Items | -89.50 | -41.30 | -126.20 | -111.10 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -8,372.30 | -1,475.20 | 1,535.00 | 1,154.40 |
Zydus Lifesciences Dividend Zydus Lifesciences Bonus Zydus Lifesciences News Zydus Lifesciences AGM Zydus Lifesciences Rights Zydus Lifesciences Splits Zydus Lifesciences Board Meetings Zydus Lifesciences Key Metrics Zydus Lifesciences Shareholdings Zydus Lifesciences Profit Loss Zydus Lifesciences Balance Sheet Zydus Lifesciences Q1 Results Zydus Lifesciences Q2 Results Zydus Lifesciences Q3 Results Zydus Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks